Download Free Sample Report

Drug Eluting Peripheral Stents Market, Global Outlook and Forecast 2023-2032

Drug Eluting Peripheral Stents Market, Global Outlook and Forecast 2023-2032

  • Published on : 08 February 2023
  • Pages :73
  • Report Code:SMR-7554848

Download Report PDF Instantly

Leave This Empty:

Secure

Report overview

This report contains market size and forecasts of Drug Eluting Peripheral Stents in global, including the following market information:
Global Drug Eluting Peripheral Stents Market Revenue, 2018-2023, 2023-2032, ($ millions)
Global Drug Eluting Peripheral Stents Market Sales, 2018-2023, 2023-2032, (K Units)
Global top five Drug Eluting Peripheral Stents companies in 2022 (%)
The global Drug Eluting Peripheral Stents market was valued at US$ million in 2022 and is projected to reach US$ million by 2032, at a CAGR of % during the forecast period 2023-2032.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million by 2032.
Carotid Artery Segment to Reach $ Million by 2032, with a % CAGR in next six years.
The global key manufacturers of Drug Eluting Peripheral Stents include Boston Scientific Corporation, W. L. Gore & Associates, Abbott Laboratories, iVascular SLU., Meril Life Sciences Pvt. Ltd. and Stentys SA, Cook Medical Inc., etc. In 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Drug Eluting Peripheral Stents manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Drug Eluting Peripheral Stents Market, by Type, 2018-2023, 2023-2032 ($ Millions) & (K Units)
Global Drug Eluting Peripheral Stents Market Segment Percentages, by Type, 2022 (%)
Carotid Artery
Iliac Artery
Infrapop Artery
Renal Artery
Carotid Artery
Global Drug Eluting Peripheral Stents Market, by Application, 2018-2023, 2023-2032 ($ Millions) & (K Units)
Global Drug Eluting Peripheral Stents Market Segment Percentages, by Application, 2022 (%)
Hospitals
Specialty Clinics
Ambulatory Surgical Centers/Outpatients
Global Drug Eluting Peripheral Stents Market, By Region and Country, 2018-2023, 2023-2032 ($ Millions) & (K Units)
Global Drug Eluting Peripheral Stents Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Drug Eluting Peripheral Stents revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Drug Eluting Peripheral Stents revenues share in global market, 2022 (%)
Key companies Drug Eluting Peripheral Stents sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Drug Eluting Peripheral Stents sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Boston Scientific Corporation
W. L. Gore & Associates
Abbott Laboratories
iVascular SLU.
Meril Life Sciences Pvt. Ltd.
Stentys SA, Cook Medical Inc.